Morgan Stanley Finance LLC Files 424B2 Prospectus Supplement

TL;DR

**MS is issuing new securities, likely debt, under a routine prospectus supplement.**

AI Summary

This 424B2 filing from March 24, 2026, indicates that Morgan Stanley Finance LLC, a subsidiary of Morgan Stanley, is offering new securities under its existing registration statement (File No. 333-275587-01). This is a routine prospectus supplement, likely detailing the terms of a specific debt or structured product offering. For investors, it means Morgan Stanley is actively raising capital, which can be a sign of growth initiatives or refinancing efforts, but the specific impact depends on the terms of the securities being offered, which are not fully detailed in this summary filing.

Why It Matters

This filing signals Morgan Stanley Finance LLC is issuing new securities, which could impact the company's capital structure and future financial obligations.

Risk Assessment

Risk Level: low — This is a standard prospectus supplement filing, indicating a routine capital-raising activity rather than an event with immediate high risk.

Analyst Insight

Investors should monitor subsequent filings or news releases for the specific terms (e.g., interest rates, maturity dates, use of proceeds) of the securities being offered by Morgan Stanley Finance LLC to assess the potential impact on the parent company's financial health and future earnings.

Key Numbers

• 2026-03-24 — Filing Date (The date the 424B2 was filed and accepted by the SEC.)
• 333-275587-01 — Registration Statement File No. (The specific registration statement under which Morgan Stanley Finance LLC is offering securities.)
• 15,124 — Preliminary Pricing Supplement No. (Indicates this is a specific offering under a series of supplements.)

Key Players & Entities

• Morgan Stanley Finance LLC (company) — the filer of the 424B2 prospectus supplement
• Morgan Stanley (company) — the parent company of Morgan Stanley Finance LLC
• 0001666268 (person) — CIK for Morgan Stanley Finance LLC
• 0000895421 (person) — CIK for Morgan Stanley
• 333-275587-01 (dollar_amount) — File Number for Morgan Stanley Finance LLC's registration statement
• 333-275587 (dollar_amount) — File Number for Morgan Stanley's registration statement
• 2026-03-24 (dollar_amount) — Filing Date

Forward-Looking Statements

• Morgan Stanley Finance LLC will successfully issue the securities detailed in this prospectus supplement. (Morgan Stanley Finance LLC) — high confidence, target: 2026-04-30

FAQ

Key Financial Figures

• $1,000 — an Stanley Stated principal amount: $1,000 per security Issue price: $1,000 pe
• $973.00 — ue on the pricing date: Approximately $973.00 per security, or within $40.00 of that
• $40.00 — imately $973.00 per security, or within $40.00 of that estimate. See "Estimated Value
• $1,141.00 — t (per Security) #1 April 6, 2027 $1,141.00 #2 May 5, 2027 $1,152.75 #3 J
• $1,152.75 — , 2027 $1,141.00 #2 May 5, 2027 $1,152.75 #3 June 3, 2027 $1,164.50 #4
• $1,164.50 — 2027 $1,152.75 #3 June 3, 2027 $1,164.50 #4 July 6, 2027 $1,176.25 #5
• $1,176.25 — 2027 $1,164.50 #4 July 6, 2027 $1,176.25 #5 August 4, 2027 $1,188.00 #6
• $1,188.00 — 027 $1,176.25 #5 August 4, 2027 $1,188.00 #6 September 3, 2027 $1,199.75
• $1,199.75 — $1,188.00 #6 September 3, 2027 $1,199.75 #7 October 5, 2027 $1,211.50 #8
• $1,211.50 — 27 $1,199.75 #7 October 5, 2027 $1,211.50 #8 November 3, 2027 $1,223.25 #
• $1,223.25 — 7 $1,211.50 #8 November 3, 2027 $1,223.25 #9 December 3, 2027 $1,235.00 #
• $1,235.00 — 7 $1,223.25 #9 December 3, 2027 $1,235.00 #10 January 5, 2028 $1,246.75 #
• $1,246.75 — 7 $1,235.00 #10 January 5, 2028 $1,246.75 #11 February 3, 2028 $1,258.50
• $1,258.50 — $1,246.75 #11 February 3, 2028 $1,258.50 #12 March 3, 2028 $1,270.25 Pag
• $1,270.25 — 028 $1,258.50 #12 March 3, 2028 $1,270.25 Page 2 Morgan Stanley Finance LLC

Filing Documents

• ms15124_424b2-10785.htm (424B2) — 253KB
• image1.gif (GRAPHIC) — 78KB
• image2.gif (GRAPHIC) — 83KB
• 0001839882-26-016697.txt ( ) — 476KB

Risk Factors

Risk Factors This section describes the material risks relating to the securities. For further discussion of these and other risks, you should read the section entitled "Risk Factors" in the accompanying product supplement and prospectus. We also urge you to consult with your investment, legal, tax, accounting and other advisers in connection with your investment in the securities. Risks Relating to an Investment in the Securities The securities do not guarantee the return of any principal and do not pay interest. The terms of the securities differ from those of ordinary debt securities in that they do not guarantee the repayment of any principal and do not pay interest. If we do not redeem the securities based on the output of a risk neutral valuation model prior to maturity and the final level of either underlier is less than its downside threshold level, the payout at maturity will be an amount in cash that is significantly less than the stated principal amount of each security, and you will lose an amount proportionate to the full decline in the level of the worst performing underlier over the term of the securities. There is no minimum payment at maturity on the securities, and, accordingly, you could lose your entire initial investment in the securities. If we redeem the securities based on the output of a risk neutral valuation model prior to maturity, the appreciation potential of the securities is limited by the fixed redemption payment specified for each redemption date. If we redeem the securities based on the output of a risk neutral valuation model on any redemption date, the appreciation potential of the securities is limited by the fixed redemption payment, and no further payments will be made on the securities once they have been redeemed. If the securities are redeemed prior to maturity, you will not participate in any appreciation of either underlier, which could be significant. The fixed redemption payment may be less than the payment at m

View Full Filing

View this 424B2 filing on SEC EDGAR